The WHO/ILAR core set of endpoints for rheumatoid arthritis clinical trials signifies progress in a continuing worldwide effort. This core set includes the following measures: pain, patient global assessment, physical disability, swollen joints, tender joints, acute phase reactants, and physician global assessment; in studies of one or more years' duration, radiographs of joints should be performed.
|Number of pages||4|
|Journal||Journal of Rheumatology|
|Issue number||SUPPL. 41|
|Publication status||Published - 15 Sep 1994|
- Clinical trials